Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kefir Lab is a biotechnology-driven consumer health company focused on the development and commercialization of high-potency probiotic beverages. The company leverages a proprietary fermentation platform to produce living kefir products that feature a high density of diverse microbial strains, specifically targeting the optimization of the human gut microbiome. Their product portfolio includes coconut-based and water-based probiotic shots designed to improve digestive health and bolster immune function. By bridging the gap between functional nutrition and microbial therapy, Kefir Lab provides clinical-grade probiotic solutions in a bioavailable, food-based format. The company operates its own manufacturing facilities to ensure the viability and concentration of its live active cultures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kefir Lab.